Copyright
©2012 Baishideng Publishing Group Co.
World J Gastroenterol. Sep 28, 2012; 18(36): 5072-5077
Published online Sep 28, 2012. doi: 10.3748/wjg.v18.i36.5072
Published online Sep 28, 2012. doi: 10.3748/wjg.v18.i36.5072
Table 1 Baseline characteristics of the 163 patients
| Characteristic | Value |
| Age (yr), median (range) | 60 (30-81) |
| Male/female, n | 98/65 |
| Stage, n | |
| I | 23 |
| II | 67 |
| III | 64 |
| IV | 9 |
| Follow-up duration (d), median (range) | 756 (419-1355) |
| Recurrence, n | 25 |
| Death, n | 3 |
Table 2 The maximum standardized uptake value and clinicopathologic characteristics
| SUVmax < 8.6 (n = 80) | SUVmax≥8.6 (n = 83) | P value | |
| Age (yr), median (range) | 61.0 (37-81) | 60.0 (30-81) | 0.799 |
| Sex (male), n | 47 | 51 | 0.872 |
| Stage, n | 0.346 | ||
| I | 15 | 8 | |
| II | 33 | 34 | |
| III | 28 | 36 | |
| IV | 4 | 5 | |
| Tumor size (cm), median (range) | 4.0 (2-13.5) | 4.5 (2.4-9.5) | 0.02 |
| T stage, n | 0.01 | ||
| 1 | 5 | 3 | |
| 2 | 12 | 8 | |
| 3 | 59 | 57 | |
| 4 | 4 | 15 | |
| N stage, n | 0.955 | ||
| 0 | 47 | 44 | |
| 1 | 17 | 24 | |
| 2 | 16 | 15 | |
| M stage, n | 0.562 | ||
| 0 | 76 | 78 | |
| 1 | 4 | 5 | |
| Histology | 0.54 | ||
| WD | 6 | 7 | |
| MD | 71 | 67 | |
| PD | 4 | ||
| Mucinous | 3 | 5 | |
| Median follow-up (d) | 776 | 756 | 0.285 |
| Recurrence, n | 14 | 11 | 0.509 |
| Death, n | 2 | 1 | 0.547 |
Table 3 Two-year disease-free survival according to the Kaplan-Meier method
| Variable | No. of patients | Two-year DFS (%) | Log-rank P |
| Age (yr) | 0.29 | ||
| ≥ 60 | 81 | 90.1 | |
| < 60 | 82 | 85.4 | |
| Sex | 0.08 | ||
| Male | 98 | 83.7 | |
| Female | 65 | 93.8 | |
| TNM stage | < 0.01 | ||
| I | 23 | 100 | |
| II | 67 | 98.5 | |
| III | 64 | 78.1 | |
| IV | 9 | 44.4 | |
| SUVmax | 0.53 | ||
| ≥ 8.6 | 83 | 86.7 | |
| < 8.6 | 80 | 88.8 | |
| CEA (ng/mL) | < 0.01 | ||
| > 5 | 36 | 72.2 | |
| ≤ 5 | 123 | 93.5 |
Table 4 Multivariate Cox regression analysis of disease-free survival
| Variable | Relative risk | 95% CI | P value |
| SUVmax ≥ 8.6 | 0.8 | 0.35-2.16 | 0.76 |
| T stage (T3, T4) | 3.1 | 0-6.6 | 0.94 |
| N stage (N2) | 9.78 | 2.01-49.5 | 0.01 |
| M stage (M1) | 2.51 | 0.78-7.98 | 0.12 |
| Age ≥ 60 yr | 0.6 | 0.35-2.16 | 0.35 |
| Male | 1.9 | 0.71-5.15 | 0.20 |
| CEA > 5 ng/mL | 3.2 | 1.26-8.42 | 0.02 |
- Citation: Lee JE, Kim SW, Kim JS, Choi KY, Kang WK, Oh ST, Yoo IR, Kim SH. Prognostic value of 18-fluorodeoxyglucose positron emission tomography-computed tomography in resectable colorectal cancer. World J Gastroenterol 2012; 18(36): 5072-5077
- URL: https://www.wjgnet.com/1007-9327/full/v18/i36/5072.htm
- DOI: https://dx.doi.org/10.3748/wjg.v18.i36.5072
